Seres Therapeutics
MCRB
MCRB
33 hedge funds and large institutions have $25.4M invested in Seres Therapeutics in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less capital invested
Capital invested by funds: $43.1M → $25.4M (-$17.7M)
48% less funds holding
Funds holding: 63 → 33 (-30)
78% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 37
Holders
33
Holding in Top 10
1
Calls
$2.23M
Puts
$253K
Top Buyers
| 1 | +$1.02M | |
| 2 | +$289K | |
| 3 | +$249K | |
| 4 |
Squarepoint
New York
|
+$232K |
| 5 |
BlackRock
New York
|
+$147K |
Top Sellers
| 1 | -$9.17M | |
| 2 | -$725K | |
| 3 | -$269K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$139K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$95.6K |
